🔎 Trials Near Me

Home › Quitting Smoking › NCT07447635

Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

RecruitingHealthy volunteers welcome

Smoking Cessation and Alcohol Use Among Cancer Survivors: Investigating the Efficacy of a Mindfulness-Based Intervention

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* ≥18 years old
* History of a cancer diagnosis at any point in lifetime
* Smoked ≥1 cigarette/day in past month
* At least one binge drinking episode in past month or exceeds weekly drinking limits
* Motivated to quit smoking and modify alcohol use in next 30 days
* Valid home address in Florida
* English-speaking, reading, and writing ability

Exclusion Criteria:

* Pregnancy or lactation
* Active psychotic disorder
* History of severe alcohol withdrawal
* Current use of tobacco cessation medication or other treatments to quit smoking
* End-of-life or hospice care
* Household member already enrolled

About the study

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

What is being tested

Sponsor: H. Lee Moffitt Cancer Center and Research Institute · Participants: 600 · Started: May 15, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07447635

Locations in the U.S.

FloridaMoffitt Cancer Center, Tampa

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.